Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 2
2015 2
2016 4
2017 4
2018 3
2019 2
2020 5
2021 4
2022 7
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Functional Outcomes After Localized Prostate Cancer Treatment.
Al Hussein Al Awamlh B, Wallis CJD, Penson DF, Huang LC, Zhao Z, Conwill R, Talwar R, Morgans AK, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, O'Neil BB, Koyama T, Hoffman KE, Barocas DA. Al Hussein Al Awamlh B, et al. JAMA. 2024 Jan 23;331(4):302-317. doi: 10.1001/jama.2023.26491. JAMA. 2024. PMID: 38261043
Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer.
Tallman JE, Wallis CJD, Zhao Z, Huang LC, Penson DF, Koyama T, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Hoffman KE, Barocas DA. Tallman JE, et al. Prostate Cancer Prostatic Dis. 2023 Dec;26(4):787-794. doi: 10.1038/s41391-022-00627-1. Epub 2022 Dec 8. Prostate Cancer Prostatic Dis. 2023. PMID: 36482081
Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness Study.
De B, Pasalic D, Barocas DA, Wallis CJD, Huang LC, Zhao Z, Koyama T, Tang C, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson DF, Hoffman KE. De B, et al. J Urol. 2022 Dec;208(6):1226-1239. doi: 10.1097/JU.0000000000002902. Epub 2022 Aug 25. J Urol. 2022. PMID: 36006050 Free PMC article.
Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer.
Tallman JE, Wallis CJD, Huang LC, Zhao Z, Penson DF, Koyama T, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Barocas DA, Hoffman KE. Tallman JE, et al. Prostate Cancer Prostatic Dis. 2023 Mar;26(1):80-87. doi: 10.1038/s41391-022-00518-5. Epub 2022 Feb 25. Prostate Cancer Prostatic Dis. 2023. PMID: 35217831
Association between Treatment for Localized Prostate Cancer and Mental Health Outcomes.
Luckenbaugh AN, Wallis CJD, Huang LC, Wittmann D, Klaassen Z, Zhao Z, Koyama T, Laviana AA, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Hoffman KE, Penson DF, Barocas DA. Luckenbaugh AN, et al. J Urol. 2022 May;207(5):1029-1037. doi: 10.1097/JU.0000000000002370. Epub 2022 Mar 3. J Urol. 2022. PMID: 34978488 Free PMC article.
Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer.
Wallis CJD, Zhao Z, Huang LC, Penson DF, Koyama T, Kaplan SH, Greenfield S, Luckenbaugh AN, Klaassen Z, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Hoffman KE, Barocas DA. Wallis CJD, et al. JAMA Oncol. 2022 Jan 1;8(1):50-59. doi: 10.1001/jamaoncol.2021.5160. JAMA Oncol. 2022. PMID: 34792527 Free PMC article.
Association between pelvic nodal radiotherapy and patient-reported functional outcomes through 5 years among men undergoing external-beam radiotherapy for prostate cancer: An assessment of the comparative effectiveness analysis of surgery and radiation (CEASAR) cohort.
Wallis CJD, Huang LC, Zhao Z, Penson DF, Koyama T, Conwill R, Tallman JE, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Barocas DA, Hoffman KE. Wallis CJD, et al. Urol Oncol. 2022 Feb;40(2):56.e1-56.e8. doi: 10.1016/j.urolonc.2021.04.035. Epub 2021 Jun 19. Urol Oncol. 2022. PMID: 34154899 Free PMC article.
Five-year outcomes from a prospective comparative effectiveness study evaluating external-beam radiotherapy with or without low-dose-rate brachytherapy boost for localized prostate cancer.
Pasalic D, Barocas DA, Huang LC, Zhao Z, Koyama T, Tang C, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup AM, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson DF, Hoffman KE. Pasalic D, et al. Cancer. 2021 Jun 1;127(11):1912-1925. doi: 10.1002/cncr.33388. Epub 2021 Feb 17. Cancer. 2021. PMID: 33595853 Free article.
Patient-Reported Financial Toxicity Associated with Contemporary Treatment for Localized Prostate Cancer.
Stone BV, Laviana AA, Luckenbaugh AN, Huang LC, Zhao Z, Koyama T, Conwill R, Hoffman K, Joyce DD, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson DF, Barocas DA. Stone BV, et al. J Urol. 2021 Mar;205(3):761-768. doi: 10.1097/JU.0000000000001423. Epub 2020 Nov 30. J Urol. 2021. PMID: 33252300
29 results